iCAD
Nashua
About iCAD
iCAD provides cancer detection and therapy solutions. Their breast health solutions provide software solutions for digital breast tomosynthesis and breast density. Breast cancer solutions also provide tools to support disease detection and analysis.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $59.5M
- Funding stage: M&A
- Last round: Post-IPO Equity (Mar 2021)
- Ticker: nasdaq:ICAD
- Website: icadmed.com
- Phone: +1 866 280 2239
Industries & Categories
Health Care, Health Diagnostics, Medical Device, Software
Social Profiles
Canonical: https://fsome.com/organization/icad-133851 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.